Metraipolis › archive › dc_0cb42fc0c694
Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics — Europe PMC PMID:41716960
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41716960
- DOI
- 10.1002/mco2.70634
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T15:20:32.606Z
- SHA-256 of the archived text
818a085ce988e53553fc7690d03695ff5ad6e8d28077620d69f1f41a0c96c4fa- Stable URL of this page
https://metraipolis.com/documento/dc_0cb42fc0c694
How to cite
Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics — Europe PMC PMID:41716960 — Europe PMC (en), https://europepmc.org/article/MED/41716960 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cb42fc0c694 (Metraipolis archive dc_0cb42fc0c694, sha256 818a085ce988e53553fc7690d03695ff5ad6e8d28077620d69f1f41a0c96c4fa)
BibTeX
@misc{dc0cb42fc0c694,
title = {Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics — Europe PMC PMID:41716960},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41716960},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cb42fc0c694; sha256 818a085ce988e53553fc7690d03695ff5ad6e8d28077620d69f1f41a0c96c4fa},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41716960. Agents can read the archived copy with the MCP tool read_document.